Stocks

Bloomberg Gold fell to a four-month low as growing optimism over a coronavirus vaccine and signs of a increasing momentum in US economic growth stifled demand for the metal as a haven. Bullion extended last week’s loss after AstraZeneca Plc said its vaccine prevented most people from developing Covid-19, marking another promising development in the quest to end the pandemic. ...

Bloomberg Global stocks, US equity futures and oil advanced as AstraZeneca Plc said its vaccine prevented most people from developing Covid-19. Energy and banking shares led markets higher in Europe, while South Korea’s stocks hit a record. Credit Agricole SA climbed 4.2% after agreeing to buy an Italian lender Credito Valtellinese for about 737 million euros ($875 million). Vaccine announcement ...

Bloomberg It may come down to another pharmaceutical breakthrough to set the tone for emerging markets headed towards 2021. Developing-nation stocks, currencies and bonds rose for a third week in the five days through Friday, and Asian markets opened strongly on Monday, as the prospect of a coronavirus vaccine roll-out in the months ahead outweighed concern that rising infections would ...

Bloomberg Traders might have surmised that rising coronavirus cases and turmoil atop the government would breed at least the beginnings of caution among investors. Not so much. In what is shaping up as a historic month for equities, exchange-traded funds focussed on US stocks were just hit with one of the biggest deluges of cash ever recorded, attracting nearly $53 ...

Bloomberg Bitcoin mania is back and with it, the return of sky-high predictions from celebrity crypto fund managers to Wall Street stalwarts of where it can go next. The world’s largest digital currency is in the midst of an exuberant rally that this week saw it cross above $18,800 for the first time in almost three years. Strategists and crypto ...

Bloomberg European stocks slipped with US futures as new virus cases continue to mount in major cities around the world. The Stoxx Europe 600 Index fell 0.2% and the Nikkei 225 Stock Average lost 1.1% after Tokyo reported a record number of new Covid-19 infections. Treasury yields and the dollar extended declines after Federal Reserve Chair Jerome Powell said the ...

Bloomberg Indian stocks were mixed, as investors weighed high valuations and surging coronavirus cases in some parts of the country against optimism that vaccines will soon provide an exit from the pandemic. The S&P BSE Sensex was little changed at 43,924.44 in Mumbai after falling as much as 0.3%, while the NSE Nifty 50 Index also traded flat. After reaching ...

Bloomberg A global stock rally powered by hopes that new Covid-19 vaccines will bolster economic growth paused on Tuesday as investors weighed the near-term spread of the virus. The Stoxx Europe 600 Index fluctuated at the open, while S&P 500 futures retreated a day after the underlying benchmark closed at an all-time high on news that Moderna Inc’s vaccine was ...

Bloomberg Indian stocks rose as favourable initial results for a second Covid-19 vaccine fanned optimism of an exit from the pandemic. The S&P BSE Sensex climbed 0.7% to 43,959.75 in Mumbai, while the NSE Nifty 50 Index advanced by the same magnitude. Both gauges extended gains from all-time high closing levels. Strategists at brokerages including Goldman Sachs, Morgan Stanley, and ...

Bloomberg Japan’s Nikkei 225 Stock Average may surpass 30,000 yen by the end of next year as corporate earnings improve amid an easy monetary policy and overseas demand for equities, according to a strategist at Daiwa Securities Co. Companies will post profits in fiscal 2021 as people and companies adapt to life with coronavirus, vaccines are developed and economic activity ...